Complex molecules – current developments Journal title: Generics and Biosimilars Initiative Journal Authors: Gerrit Borchard Subject(s):
Interchangeability. An insurmountable fifth hurdle? Journal title: Generics and Biosimilars Initiative Journal Authors: Hans C Ebbers, Paul Chamberlain Subject(s):
Pathway to affordable, quality-assured sources of pegylated interferon alpha for treating hepatitis C Journal title: Generics and Biosimilars Initiative Journal Authors: Barbara Milani, Sara Gaspani Subject(s):
The authorization of non-biological complex drugs (NBCDs) follow-on versions: specific regulatory and interchangeability rules ahead? Journal title: Generics and Biosimilars Initiative Journal Authors: Beat Flühmann, Jon SB de Vlieger, Arnold G Vulto, Stefan Mühlebach, Vera Weinstein, Vinod P Shah Subject(s):
Italy’s final position paper on biosimilars and new price and reimbursement pathway Journal title: Generics and Biosimilars Initiative Journal Authors: Gianluigi Casadei Subject(s):
Biosimilar monoclonal antibodies—challenges and opportunities in Europe Journal title: Generics and Biosimilars Initiative Journal Authors: Andrea Laslop Subject(s):
Regional tenders on biosimilars in Italy: potentially competitive? Journal title: Generics and Biosimilars Initiative Journal Authors: Alessandro Curto, Katelijne Van de Vooren, Roberta Lo Muto, Silvy Duranti, Livio Garattini Subject(s):
Licensing and prescribing biosimilars in Australia Journal title: Generics and Biosimilars Initiative Journal Authors: David A Power Subject(s):
US state legislation on biosimilars substitution Journal title: Generics and Biosimilars Initiative Journal Authors: GaBI Journal Editor Subject(s):
Biosimilars in oncology: current and future perspectives Journal title: Generics and Biosimilars Initiative Journal Authors: Matti Aapro Subject(s):
Health authority perspective on biosimilars Journal title: Generics and Biosimilars Initiative Journal Authors: Brian Godman Subject(s):
The case for biosimilars–a payer’s perspective Journal title: Generics and Biosimilars Initiative Journal Authors: Gustaf Befrits Subject(s):
Current status of biopharmaceuticals in Iran’s pharmaceutical market Journal title: Generics and Biosimilars Initiative Journal Authors: Abdol Majid Cheraghali Subject(s):
Biosimilars in the European market Journal title: Generics and Biosimilars Initiative Journal Authors: Joan Rovira, Leandro Lindner, Emmanuel Giménez, Jaime Espín, Antonio Olry de Labry, Leticia García Subject(s):
The future of biological therapy: a pathway forward for biosimilars Journal title: Generics and Biosimilars Initiative Journal Authors: Richard O Dolinar, Michael S Reilly Subject(s):
